Akso Health Group
Akso Health Group is a U.S.-incorporated holding company with operating subsidiaries in the United States and China that sell medical devices and offer healthcare-related services. Its business has included products such as defibrillators, anesthesia laryngoscopes, and COVID-19 rapid antigen test kits, alongside marketing promotion and online healthcare service activities tied to the healthcare sector.
Tilikausi 2026 · muutos edellisvuodesta
Kehitys 2021–2026
Liiketoiminta
Osuus liikevaihdostaSales of devices such as defibrillators and anesthesia laryngoscopes to dealers and end users.
Distribution of COVID-19 rapid antigen test kits through U.S. channels.
Contracted promotion and order-based services for insurance carriers and intermediaries.
Healthcare-service initiatives and platform-based offerings for medical and consulting partners.
Tuotteet
Raportoitu · osuus liikevaihdosta- Revenue From Marketing Promotion Service97,2 %
- Revenue From Sale of Medical Devices2,8 %
Lähde: 20-F FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.
Asiakkaat
Akso sells medical devices to medical product dealers and to end users such as hospitals, while its U.S. test-kit business serves distributors. In China, its marketing promotion services are sold to insurance carriers and insurance intermediaries, and its healthcare-service initiatives target companies involved in health consulting and medical device sales. The customer mix is concentrated and project-based, with some relationships governed by multi-year cooperation agreements and others transacted on an order-by-order basis.
Buy defibrillators and laryngoscopes for resale into healthcare channels.
Purchase medical devices for direct clinical use and procurement needs.
Buy marketing promotion services under cooperation agreements in China.
Purchase COVID-19 rapid antigen test kits for downstream distribution.
Engage for online healthcare and consulting-related service initiatives.
Strategia
Akso’s stated direction is to build healthcare-related businesses around medical devices, online healthcare services, and adjacent promotion/service arrangements. The company has also used subsidiary formation and market entry in China and the U.S. to broaden its operating base and develop multiple revenue streams. Its reported initiatives suggest a strategy of pursuing healthcare-sector opportunities where it can combine product distribution with service relationships.
Reduces dependence on any one product or service line and increases optionality.
China is central to the company's device and service activity and partner access.
U.S. and China channels support different customer sets and revenue sources.
Maantiede
Akso is structured across the United States and Greater China, with U.S. entities used for test-kit distribution and Chinese subsidiaries used for medical device sales and healthcare-related services. The reports also show entities in Wyoming, Shandong, Tianjin, Hong Kong, and the British Virgin Islands, reflecting a cross-border operating and holding-company structure. Geography matters because product sales, service contracts, and regulatory regimes differ materially between the U.S. and China.
Riskit
Akso’s business is exposed to customer concentration, regulatory compliance, and execution risk across multiple business lines. Its healthcare and marketing activities involve medical, data, and contractual requirements, while goodwill impairment and acquisition-related issues show that valuation and integration judgments can materially affect results. Cross-border operations also increase exposure to U.S. and PRC legal, licensing, and operational risks.
- Customer concentrationVaikutus: KorkeaTodennäköisyys: Korkea
A few customers accounted for a large share of marketing service revenue and receivables.
Kohdistuu: Marketing promotion services
- Healthcare regulatory complianceVaikutus: KorkeaTodennäköisyys: Korkea
Medical device sales and online healthcare services are subject to health, privacy, and licensing rules.
Kohdistuu: U.S. and China operations
- Goodwill impairmentVaikutus: KorkeaTodennäköisyys: Korkea
The company recorded a material impairment tied to lower projected revenue growth and profitability assumptions.
Kohdistuu: Acquired healthcare businesses
- Medical liability claimsVaikutus: KorkeaTodennäköisyys: Kohtalainen
Online healthcare and medical-related activities can trigger claims for service errors or patient harm.
Kohdistuu: Healthcare services
- Cross-border executionVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Operating through multiple subsidiaries across jurisdictions increases legal and operational complexity.
Kohdistuu
Kirjanpito
Harkinnanvaraiset erätManagement estimates can materially change carrying value and operating results.
Vaikutus: Can create large non-cash charges when forecasts weaken
Device sales, distributor sales, and weekly service fees may be recognized differently.
Vaikutus: Affects timing and comparability of revenue across periods
Customer concentration increases the need to assess credit risk and allowances.
Vaikutus: Can affect net receivables and bad-debt expense
Reporting-unit and asset fair values rely on management assumptions.
Vaikutus: Influences impairment conclusions and balance-sheet carrying values
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Longduoduo Co Ltd
LDDD · Services-Health Services
Longduoduo Co Ltd is a U.S.-listed company with operating subsidiaries in Inner Mongolia and Beijing that generates revenue from two main activities: direct…
VASO Corp
VASO · Electromedical & Electrotherapeutic Apparatus
VASO Corp is a U.S.-based healthcare and information technology company organized around three operating segments: healthcare IT and managed network services,…
Adagio Medical Holdings, Inc.
ADGM · Surgical & Medical Instruments & Apparatus
Shineco, Inc.
Agricultural Production-Crops
Axsome Therapeutics, Inc.
AXSM · Pharmaceutical Preparations
Axsome Therapeutics is a U.S.-based biopharmaceutical company focused on central nervous system (CNS) disorders, with a commercial portfolio built around AUVELITY, SUNOSI, and SYMBRAVO.
Work Medical Technology Group LTD
WOK · Surgical & Medical Instruments & Apparatus
WORK Medical Technology Group LTD is a medical device company with operating subsidiaries in China that develops and manufactures Class I and II medical devices and sells disposable medical products.
Päivitetty: 28.9.2026